Tapentadol, Screen Only, Urine

CPT: 80307
Print Share

Test Details


  • Nucynta®


Drug analysis/clinical drug monitoring


For in vitro diagnostic use only

This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).


Immunoassay (IA)

Specimen Requirements




20 mL


Plastic urine container


Urine temperature monitoring is recommended to ensure valid specimen collection.

Storage Instructions

Maintain specimen at room temperature. If arrival at lab will extend beyond seven days, refrigerate.

Causes for Rejection

Quantity not sufficient for analysis; incorrect specimen; incomplete specimen identification

Clinical Information

Special Instructions

This assay is intended for pain management. It is not intended for workplace testing and does not comply with state regulatory workplace testing programs.


Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
701900 Tapentadol, Urine 701902 Tapentadol, Urine ng/mL 72485-6
701900 Tapentadol, Urine 733163 Please Note: 77202-0

For Providers

Please login to order a test.


© 2019  Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2018, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf